{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:12:04Z","timestamp":1790223124232,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant for Infrastructure for Population Research at Princeton University","award":["R24HD047879"],"award-info":[{"award-number":["R24HD047879"]}]}],"content-domain":{"domain":["contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.contraception.2014.03.018","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T03:02:29Z","timestamp":1397358149000},"page":"142-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population"],"prefix":"10.1016","volume":"90","author":[{"given":"Christoph","family":"Gerlinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Trussell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Mellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Merz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Bannemerschult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilka","family":"Schellschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Endrikat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2014.03.018_bb0005","first-page":"153","article-title":"Clinical pearls: factors affecting reported contraceptive efficacy rates in clinical studies","volume":"47","author":"Burkman","year":"2002","journal-title":"Int J Fertil Womens Med"},{"key":"10.1016\/j.contraception.2014.03.018_bb0010","unstructured":"Orleans RJ, Center for Drug Evaluation and Research, Application number 22-262, LoSeasonique\u2122, October 23, 2008."},{"key":"10.1016\/j.contraception.2014.03.018_bb0015","unstructured":"Center for Drug Evaluation and Research, Application number 022501Orig1s000. Lo Loestrin Fe, October 4, 2010."},{"issue":"1420","key":"10.1016\/j.contraception.2014.03.018_bb0020","first-page":"54","article-title":"Quartette: an ascending-dose, extended-cycle oral contraceptive","volume":"55","year":"2013","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/j.contraception.2014.03.018_bb0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","article-title":"An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen","volume":"61","author":"Parsey","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.03.018_bb0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2014.03.018_bb0035","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.contraception.2013.04.001","article-title":"The creeping pearl: why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills?","volume":"88","author":"Trussell","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.03.018_bb0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.contraception.2011.12.009","article-title":"Bleeding profile of a flexible extended regimen of ethinylestradiol\/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study","volume":"86","author":"Jensen","year":"2012","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2014.03.018_bb0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/13625187.2013.780202","article-title":"Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate\/dienogest: a pooled analysis of three studies conducted in North America and Europe","volume":"18","author":"Nelson","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"7211","key":"10.1016\/j.contraception.2014.03.018_bb0055","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.contraception.2014.03.018_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/ejc.8.2.87.92","article-title":"Recommendation for confidence interval and sample size calculation for the Pearl Index","volume":"8","author":"Gerlinger","year":"2003","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2014.03.018_bb0080","series-title":"Presented at the 60th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, May 5\u20139, 2012, San Diego, CA","article-title":"Comparative phase 3 study of AG200-15, a low-dose estrogen and levonorgestrel contraceptive patch","author":"Kaunitz","year":"2012"},{"key":"10.1016\/j.contraception.2014.03.018_bb0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.03.018_bb0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.09.019","article-title":"Predictors of noncompliance in an oral contraceptive clinical trial","volume":"85","author":"Westhoff","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.03.018_bb0100","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2013.03.024","article-title":"Adherence to hormonal contraception among women veterans: differences by race\/ethnicity and contraceptive supply","volume":"209","author":"Borrero","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.03.018_bb0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.contraception.2012.05.106","article-title":"Increased compliance independent of patient demographics with a low-dose combination contraceptive patch (AG200-15) compared with a low-dose combination oral contraceptive in a phase 3 clinical trial","volume":"86","author":"Kaunitz","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.03.018_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.03.018_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2007.09.013","article-title":"Estimates of contraceptive failure from the 2002 National Survey of Family Growth","volume":"77","author":"Kost","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.03.018_bb0120","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2011.07.013","article-title":"Unintended pregnancy in the United States: incidence and disparities, 2006","volume":"84","author":"Finer","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.03.018_bb0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jfprhc-2011-100213","article-title":"Contraceptive efficacy and tolerability of ethinylestradiol 20 \u03bcg\/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study","volume":"38","author":"Klipping","year":"2012","journal-title":"J Fam Plann Reprod Health Care"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414001528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414001528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T01:20:48Z","timestamp":1538702448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782414001528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0010782414001528"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2014.03.018","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2014.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}